gip and glp 1 receptor agonist GLP-1 Agonists Explained for Pharmacy & Medical Students: Mechanism, Uses, Side Effects GLP1-GIP receptor co-agonists: a promising

In the SURPASS 2 trial, Tirzepatide, at all doses (5mg, 10mg and 15mg) was more effective at lowering Hba1c and blood glucose levels compared to Semaglutide 1mg, aka Ozempic

Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study

Obesity is a multifaceted disease that contributes directly and indirectly to atherosclerotic CVD, heart failure, atrial fibrillation and multiple CVD risk factors, including dyslipidaemia, type 2 diabetes, hypertension and sleep disorders (Figure)

Further studies with longterm followup are needed to elucidate the role of GLP1 RAs in thyroid and medullary thyroid carcinomas

The American Diabetes Association

doi: 10.1016/j.neuropharm.2014.04.007 100 CuiSSFengXBZhangBHXiaZYZhanLY